Direct-to-Consumer/Patient Advertising of Genetic Testing: A Position Statement of the American College of Clinical Pharmacology

被引:16
作者
Ameer, Barbara [1 ]
Krivoy, Norberto [2 ,3 ,4 ]
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08903 USA
[2] B Rappaport & Rambam Ctr Translat Genet, B Rappaport Inst Res Med Sci, Haifa, Israel
[3] Clin Pharmacol Inst, Div Med, Haifa, Israel
[4] Technion Israel Inst Technol, Haifa, Israel
关键词
Pharmacogenetics; regulatory/scientific affairs; disease management; education; family medicine; clinical pharmacology;
D O I
10.1177/0091270009335948
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:886 / 888
页数:3
相关论文
共 7 条
[1]   American college of clinical pharmacology position statement on the use of microdosing in the drug development process [J].
Bertino, Joseph S., Jr. ;
Greenberg, Howard E. ;
Reed, Michael D. .
JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (04) :418-422
[2]   Ethical, legal, and social implications of genomic medicine [J].
Clayton, EW .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (06) :562-569
[3]  
*FED TRAD COMM, 2006, AT HOM GEN TESTS HLT
[4]  
*GEN PUBL POL CTR, WHO REG GEN TESTS
[5]   Oversight of US genetic testing laboratories [J].
Hudson, Kathy L. ;
Murphy, Juli A. ;
Kaufman, David J. ;
Javitt, Gail H. ;
Katsanis, Sara H. ;
Scott, Joan .
NATURE BIOTECHNOLOGY, 2006, 24 (09) :1083-1090
[6]   The regulation of direct-to-consumer genetic tests [J].
Kaye, Jane .
HUMAN MOLECULAR GENETICS, 2008, 17 :R180-R183
[7]  
*UD DEP HHS, 1999, GUID IND CONS DIR BR